​Our Mission
Facilitate a new diagnostic paradigm in the field of gene therapy, where the effectiveness, distribution, and extent of treatment can be observed and assessed in real-time.
​
We work collaboratively with innovators driving progress for the betterment of patient care and disease treatment worldwide.
​Our Story
In the early 2020s, a visionary team of seasoned professionals, led by Thomas J. Meade, embarks on a revolutionary journey with the creation of PreDx, a company centered around developing imaging technology that promises to transform the field of gene therapy.
​
By creating unique bio-responsive contrast agents (BCAs), PreDx's technology allows for the real-time, non-invasive monitoring of gene expression in living organisms, a breakthrough of significant importance that stands alone in its capacity to make visible the previously unseen.
​
The concept is simple but elegant: BCAs can detect repaired or inserted gene expression products, triggering a measurable change in contrast on MR images. They are capable of making visible the physiological changes brought about by gene therapies, offering valuable insights into the biodistribution and activity levels of these therapies, something that is previously unattainable by non-invasive means.
Thomas J. Meade (Founder) is a distinguished professor at Northwestern University across multiple disciplines, has made a significant impact in the field of biotechnology, founding five innovative companies focused on revolutionary medical diagnostics and treatments. His entrepreneurial prowess is exemplified by the success of Clinical MicroSensors, which was sold to Roche in 2021 for $1.8 billion, demonstrating the immense value of his pioneering work.
​
Kurt Zoller (CEO) is a prominent leader in the health sector, utilizing his expertise in marketing and communications to create impactful campaigns, notably managing a $10 million budget at Northwestern Medicine and fostering growth of over 150% at Epsilon Healthcare. His accomplishments extend beyond the corporate world, as he's demonstrated commitment to community service as president of the Wilmette Rotary Club and marketing committee leader for Prevent Blindness, reinforcing his multifaceted influence in healthcare and beyond.
